SCHEMBL8403335

SCHEMBL8403335

CCCOc1ccc([C@H](C)C(=O)O)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR88 Q9GZN0 2/20 0.59
AKR1C3 P42330 2/20 0.56
AKR1C2 P52895 1/20 0.56
PTGS2 P35354 2/20 0.55
ACACB O00763 6/20 0.54
LMNA P02545 2/20 0.53
L3MBTL1 Q9Y468 2/20 0.53
ACACA Q13085 4/20 0.52
KDM4E B2RXH2 1/20 0.51
ALB P02768 1/20 0.50
ESR1 P03372 1/20 0.50
ALOX5 P09917 1/20 0.50
RARB P10826 1/20 0.50
CYP2C9 P11712 1/20 0.50
ADRB3 P13945 1/20 0.50
NFKB1 P19838 1/20 0.50
PTGS1 P23219 1/20 0.50
HTR2A P28223 1/20 0.50
NR1I3 Q14994 1/20 0.50
SLC22A6 Q4U2R8 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7403967 1.00 GPR88 (0.59) GPR88AKR1C3AKR1C2PTGS2ACACB
SCHEMBL14599721 0.93 GPR88 (0.59) GPR88AKR1C3AKR1C2PTGS2LMNA
SCHEMBL456460 0.92 ACACB (0.65) GPR88AKR1C3AKR1C2ACACB
SCHEMBL9861070 0.90 LMNA (0.62) GPR88AKR1C3AKR1C2LMNAL3MBTL1
SCHEMBL14599980 0.89 LMNA (0.64) GPR88LMNARARB
SCHEMBL6414796 0.89 LMNA (0.64) GPR88LMNARARB
SCHEMBL5881684 0.86 AKR1C3 (0.73) AKR1C3AKR1C2PTGS2ACACBLMNA
SCHEMBL8463046 0.85 AKR1C3 (0.51) GPR88AKR1C3AKR1C2PTGS2LMNA
SCHEMBL11595380 0.85 POLB (0.51) GPR88AKR1C3AKR1C2PTGS2LMNA
SCHEMBL1346573 0.85 POLB (0.51) GPR88AKR1C3AKR1C2PTGS2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8436183-B2 Synthetic multimerizing agents ARIAD PHARMACEUTICALS, INC. (US) 2013-05-07 US disclosed
US-8436183-B2 Synthetic multimerizing agents ARIAD PHARMACEUTICALS, INC. (US) 2013-05-07 US disclosed
US-20120130076-A1 Synthetic Multimerizing Agents ARIAD PHARMACEUTICALS, INC. (US) 2012-05-24 US disclosed
US-8106191-B2 Compounds based on N- acyl-pipecolyl and N-acyl-prolyl ligand moieties for multimerizing chimeric proteins containing immunophilin-derived domains ARIAD PHARMACEUTICALS, INC. (US) 2012-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120130076-A1 Synthetic Multimerizing Agents FKBP1B, FKBP2, FKBP14 GPR88 3067/4885AKR1C3 4353/4885AKR1C2 4475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.